Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Regents of the University of CA”

3,501 pharma patents match "Regents of the University of CA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,501
Index total 30,257
Page 54 / 146

Quick answer

This filtered view shows 3,501 pharmaceutical patents matching "Regents of the University of CA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,501 results for “Regents of the University of CA” · 30,257 patents in full index Clear search

  1. US 10107816

    G-protein coupled receptor-associated diagnostics and therapeutics for B-cell chronic lymphocytic leukemia

    The Regents of the University of California · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  2. US 10100367

    Diagnosing and monitoring CNS malignancies using microRNA

    The Regents of the University of California · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  3. US 10100083

    Leukemia stem cell targeting ligands and methods of use

    The Regents of the University of California · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  4. US 10100279

    In vitro production of medial ganglionic eminence precursor cells

    The Regents of the University of California · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  5. US 10098839

    Hydrogel toxin-absorbing or binding nanoparticles

    The Regents of the University of California · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  6. US 10093745

    Anti-CSPG4 fusions with interferon for the treatment of malignancy

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  7. US 10092596

    Tungstate treatment of the dysbiosis associated with gastrointestinal inflammation

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  8. US 10092580

    Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  9. US 10093694

    Compounds for treating eye disorders or diseases

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  10. US 10087436

    Electrophysiologically mature cardiomyocytes and methods for making same

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  11. US 10087431

    Methods of generating nucleic acid fragments

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  12. US 10087413

    Thin film cell encapsulation devices

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  13. US 10087252

    Methods and compositions for treating and preventing disease associated with αvβ5 integrin

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  14. US 10086088

    Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  15. US 10085997

    Method of treating microbial infections

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  16. US 10080749

    Multi-drug therapies for tuberculosis treatment

    The Regents of the University of California · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  17. US 10080745

    Piericidin bacterial inhibitors

    The Regents of the University of California Santa Cruz · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  18. US 10077300

    Activatable binding polypeptides and methods of identification and use thereof

    The Regents of the University of California · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  19. US 10077236

    Azacyclic constrained analogs of FTY720

    The Regents of the University of California · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  20. US 10076533

    Acyclic nucleoside phosphonate diesters

    The Regents of the University of California · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  21. US 10076532

    Acyclic nucleoside phosphonate diesters

    The Regents of the University of California · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  22. US 10071110

    Phosphonate compounds

    The Regents of the University of California · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  23. US 10071101

    Use of cinnabarinic acid as a modulator of immune response in autoimmune disorders

    The Regents of the University of California · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  24. US 10071142

    Enzymes and methods for cleaving N-glycans from glycoproteins

    The Regents of the University of California · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.